(2026). Pharmacokinetics of hyaluronidase-facilitated subcutaneous immunoglobulin 10% in pediatric patients with primary immunodeficiency disease. Immunotherapy Advances.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Pharmacokinetics of Hyaluronidase-facilitated Subcutaneous Immunoglobulin 10% in Pediatric Patients with Primary Immunodeficiency Disease."
Immunotherapy Advances 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Pharmacokinetics of Hyaluronidase-facilitated Subcutaneous Immunoglobulin 10% in Pediatric Patients with Primary Immunodeficiency Disease."
Immunotherapy Advances, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.